GAGNON ROBERT E. (Chief Financial Officer) sold 1.3% of their position (7.84K shares) of OPUS GENETICS, INC. on the open market
Open‑market sale worth $40.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/27/2026ACC: 0000905148-26-001862
Officer· Chief Financial Officer
Since Sep 2025
-7.84K
Net shares
Net seller
$40.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
7.84K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.84K
Price / share
$5.18
Trade value
$40.66K
% of position
1.3%
4/23/2026
600K→592.16K
Total
Net shares
−7.84K
Net value
-$40.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/23/2026 | S · Sale | −7.84K | $5.18 | $40.66K | 1.3% | 600K | 592.16K |
| Total | −7.84K | -$40.66K | ||||||
Derivative Transactions0
No derivative transactions reported